Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pharmacology and Therapeutics

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pharmthera.2012.03.003PMID 22465159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interactions between antidepressants and P‐glycoprotein at the blood–brain barrier: clinical significance of in vitro and in vivo findings

  2012cited by this paper
• Formulations of Fentanyl for the Management of Pain

  2012cited by this paper
• Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers

  2012cited by this paper
• Equivalency of two concentrations of fentanyl administered by the intranasal route for acute analgesia in children in a paediatric emergency department: A randomized controlled trial

  2011cited by this paper
• Effect of Formulation- and Administration-Related Variables on Deposition Pattern of Nasal Spray Pumps Evaluated Using a Nasal Cast

  2011cited by this paper
• Differential expression of organic cation transporters in normal and polyps human nasal epithelium: implications for in vitro drug delivery studies.

  2011cited by this paper
• Fentanyl sublingual tablets (Abstral): An opioid analgesic for the management of breakthrough pain in cancer patients

  2011cited by this paper
• A multicenter, placebo‐controlled, double‐blind, multiple‐crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain

  2010cited by this paper
• Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.

  2010cited by this paper
• Assessment and classification of cancer breakthrough pain: A systematic literature review

  2010cited by this paper
• Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain.

  2010cited by this paper
• Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: A prospective, randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188.

  2010cited by this paper
• Chitosan-based delivery systems for protein therapeutics and antigens.

  2010cited by this paper
• Characterization and in vitro evaluation of freeze-dried microparticles composed of granisetron-cyclodextrin complex and carboxymethylcellulose for intranasal delivery.

  2010cited by this paper
• New strategies to improve the intranasal absorption of insulin.

  2010cited by this paper
• Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein.

  2010cited by this paper
• Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study

  2010cited by this paper
• Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.

  2009cited by this paper
• 719 PHARMACOKINETICS OF INTRANASAL FENTANYL SPRAY (INFS) IN SUBJECTS WITH COMMON COLD

  2009cited by this paper
• PecSys: in situ gelling system for optimised nasal drug delivery

  2009cited by this paper
• Intranasal drug delivery: how, why and what for?

  2009cited by this paper
• Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain

  2009cited by this paper
• Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System

  2009cited by this paper
• A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial

  2009cited by this paper
• 718 PHARMACOKINETICS OF INTRANASAL FENTANYL SPRAY (INFS) IN SUBJECTS WITH SEASONAL ALLERGIC RHINITIS WITH AND WITHOUT PRIOR ADMINISTRATION OF OXYMETAZOLINE

  2009cited by this paper
• PecSys: in situ gelling system for optimised nasal drug delivery.

  2009cited by this paper
• Pharmacokinetics and Pharmacodynamics of Intranasal Versus Intravenous Fentanyl in Patients with Pain after Oral Surgery

  2008cited by this paper
• Permeation Studies and Histological Examination of Sheep Nasal Mucosa Following Administration of Different Nasal Formulations with or without Absorption Enhancers

  2008cited by this paper
• Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery.

  2008cited by this paper
• The Effect of Intranasal Administration of Remifentanil on Intubating Conditions and Airway Response After Sevoflurane Induction of Anesthesia in Children

  2008cited by this paper
• Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study.

  2008cited by this paper
• Intestinal first-pass metabolism of CYP3A4 substrates.

  2008cited by this paper
• Comparison of Intranasal Administration of Haloperidol with Intravenous and Intramuscular Administration: A Pilot Pharmacokinetic Study

  2008cited by this paper
• Population Pharmacokinetics of Intravenous, Intramuscular, and Intranasal Naloxone in Human Volunteers

  2008cited by this paper
• Mechanisms and mediators of nasal symptoms in non‐allergic rhinitis

  2008cited by this paper
• Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference?

  2008cited by this paper
• Intranasal administration of drugs.

  2008cited by this paper
• Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge

  2007cited by this paper
• Intranasal delivery: physicochemical and therapeutic aspects.

  2007cited by this paper
• Allergic rhinitis and its pharmacology.

  2007cited by this paper
• The Influence of Spray Properties on Intranasal Deposition

  2007cited by this paper
• Absorption of Fentanyl from Fentanyl Buccal Tablet in Cancer Patients With or Without Oral Mucositis

  2007cited by this paper
• Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.

  2007cited by this paper
• The treatment of breakthrough pain.

  2007cited by this paper
• A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.

  2007cited by this paper
• Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.

  2006cited by this paper
• Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant.

  2006cited by this paper
• Opioids for the management of breakthrough (episodic) pain in cancer patients.

  2006cited by this paper
• Post-Marketing Experience with an Opioid Nasal Spray for Migraine: Lessons for the Future

  2006cited by this paper
• Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent.

  2006cited by this paper
• Intranasal sufentanil is effective for postoperative analgesia in adults

  2006cited by this paper
• Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.

  2006cited by this paper
• Pharmacokinetics, Bioequivalence, and Spray Weight Reproducibility of Intranasal Butorphanol After Administration With 2 Different Nasal Spray Pumps

  2005cited by this paper
• Virtual Computational Chemistry Laboratory – Design and Description

  2005cited by this paper
• EXPRESSION OF CYTOCHROME P450 AND OTHER BIOTRANSFORMATION GENES IN FETAL AND ADULT HUMAN NASAL MUCOSA

  2005cited by this paper
• Pharmacokinetics and Dose Proportionality of Fentanyl Effervescent Buccal Tablets in Healthy Volunteers

  2005cited by this paper
• Bioavailability of intranasal butorphanol administered from a single-dose sprayer.

  2005cited by this paper
• Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.

  2005cited by this paper
• Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.

  2005cited by this paper
• Nasal drug administration: potential for targeted central nervous system delivery.

  2005cited by this paper
• Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer.

  2005cited by this paper
• Bioavailability and Pharmacokinetics of Intranasal Hydromorphone in Patients Experiencing Vasomotor Rhinitis

  2004cited by this paper
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• A Multiple-Dose Phase I Study of Intranasal Hydromorphone Hydrochloride in Healthy Volunteers

  2004cited by this paper
• The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis

  2004cited by this paper
• Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.

  2004cited by this paper
• Techniques of Intranasal Steroid Use

  2004cited by this paper
• Effect of Fluticasone Propionate Nasal Spray on Bioavailability of Intranasal Hydromorphone Hydrochloride in Patients with Allergic Rhinitis

  2004cited by this paper
• Nasal and paranasal sinus changes after radiotherapy for nasopharyngeal carcinoma

  2004cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Initial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthrough pain in cancer patients

  2003cited by this paper
• Pharmacokinetics and Bioavailability of Single-Dose Intranasal Hydromorphone Hydrochloride in Healthy Volunteers

  2003cited by this paper
• A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study

  2003cited by this paper
• Absorption Enhancers for Nasal Drug Delivery

  2003cited by this paper
• Hydromorphone Transfer into Breast Milk After Intranasal Administration

  2003cited by this paper
• The effect of nitric oxide on the permeability of nasal epithelial cells from healthy and asthmatic donors.

  2003cited by this paper
• P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation

  2003cited by this paper
• Impact of Drug Transporter Studies on Drug Discovery and Development

  2003cited by this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cited by this paper
• Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.

  2003cited by this paper
• Intranasal delivery of morphine.

  2002cited by this paper
• Sniffing neuropeptides: a transnasal approach to the human brain

  2002cited by this paper
• Permeability issues in nasal drug delivery.

  2002cited by this paper
• Disposition of nasal, intravenous, and oral methadone in healthy volunteers

  2002cited by this paper
• A Pharmacokinetic Interaction Study Between Butorphanol and Sumatriptan Nasal Sprays in Healthy Subjects: Importance of the Timing of Butorphanol Administration

  2002cited by this paper
• Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer.

  2002cited by this paper
• Insoluble Powder Formulation as an Effective Nasal Drug Delivery System

  2002cited by this paper
• Impairment of nasal mucociliary clearance after radiotherapy for childhood head cancer

  2001cited by this paper
• The biopharmaceutical aspects of nasal mucoadhesive drug delivery

  2001cited by this paper
• The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus.

  2001cited by this paper
• Bioavailability and Pharmacokinetics of Lorazepam after Intranasal, Intravenous, and Intramuscular Administration

  2001cited by this paper
• Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir.

  2001cited by this paper
• Presence of fluticasone propionate on human nasal mucosal surface and in human nasal tissue over a period of 24 h after intranasal application

  2001cited by this paper
• CFTR, MDR1, and MRP1 Immunolocalization in Normal Human Nasal Respiratory Mucosa

  2000cited by this paper
• Determination of baseline human nasal pH and the effect of intranasally administered buffers.

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study.

  2000cited by this paper
• Cellular and molecular aspects of drug transport in the kidney.

  2000cited by this paper
• Delayed Irradiation Effects on Nasal Epithelium in Patients with Nasopharyngeal Carcinoma; An Ultrastructural Study

  1999cited by this paper

• New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders

  2026cites this paper
• Nanomedicine-based therapeutic strategies for cerebral ischemia-reperfusion injury: from blood-brain barrier penetration to precision targeting.

  2026cites this paper
• Advances in mucoadhesive and mucus-penetrating materials, nano-formulations, and in situ gelling systems for nasal drug delivery.

  2026cites this paper
• From Nose to Neurons: The Emerging Role of Dissolving Microneedles in Neurodegenerative Disease Management

  2026cites this paper
• Formulation and characterization of dolutegravir sodium-loaded nanostructured lipid carrier in situ gel for targeted brain delivery via intranasal route

  2026cites this paper
• Molecular insights, challenges and progressions of polysaccharide and protein-based biopolymeric carriers for intranasal drug delivery: A review.

  2026cites this paper
• Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases.

  2026cites this paper
• Intranasal delivery of iron chelators and management of central nervous system disease

  2025cites this paper
• Development and Validation of the Augsburg Nasopharyngeal Applicator: Enhancing Efficacy in Nasal Route Brachytherapy

  2025cites this paper
• Advancements in Intranasal Delivery of Drugs for Cluster Headache Treatment using Cubosome-Based Nanocarriers: A Review

  2025cites this paper
• NIR-II Emissive, Ischemia Targeted Nanocomposites for Localized Therapeutic Hypothermia of Cerebral Ischemia-Reperfusion Injury.

  2025cites this paper
• Pharmacological Management of Cancer Pain: Advances in Treatment Strategies and Drug Delivery Systems

  2025cites this paper
• Antioxidative effects of phytoaromatic compounds on the cysteine of the SKCGS peptide as a critical aggregation domain of tau

  2025cites this paper
• Glycerol-based soft vesicular systems for nose to brain delivery of 131I-melatonin: Synthesis, Characterization, Biodistribution and Pharmacokinetic investigations

  2025cites this paper
• Efficacy of intranasal naloxone compared to other administration routes in prehospital opioid overdose management and beyond: a narrative review

  2025cites this paper
• Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery

  2025cites this paper
• Computational Insights into Intranasal Drug Delivery: Enhancing Outcomes in Pediatric Cystic Fibrosis.

  2025cites this paper
• Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans

  2025cites this paper
• Formulation and Optimisation of Mucoadhesive Nasal Powder of Celecoxib for Management of Pain Associated with Osteoarthritis

  2025cites this paper
• Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders

  2025influential citation
• Intranasal dupilumab improves responsiveness to steroid in an asthma mouse model

  2025cites this paper
• Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights

  2025cites this paper
• Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects.

  2025cites this paper
• Intranasal delivery of pApoE2 via penetratin-mannose multi-functionalized chitosan polymeric micelles to the brain: Reduced total tau and phosphorylated tau burden in transgenic Alzheimer's mouse model.

  2025cites this paper
• Pharmacokinetics of intranasal levetiracetam in healthy dogs: a feasible route of administration.

  2025cites this paper
• Intranasal Nanoliposomes Delivering Interferon Lambda with Enhanced Mucosal Retention as an Antiviral

  2025cites this paper
• Revolutionizing Aripiprazole Delivery: Improving Solubility and Permeation Via Solid dispersion and In-situ Intranasal Gelling Systems

  2025cites this paper
• Quantitative Investigation of Synthetic Mucus Effects on Spray Deposition in a 3D-Printed SLA Nasal Cavity Model

  2025cites this paper
• Quality by design enabled development & in-vitro assessment of a Nanoemulgel formulation for Nose-to-Brain delivery of Nintedanib for glioblastoma multiforme treatment.

  2025cites this paper
• Intranasal Drug Delivery: Pathways, Challenges, and Advancements in CNS Targeting

  2025cites this paper
• Intranasal drug delivery: reality and prospects

  2025cites this paper
• Optimization and Evaluation of Functionally Engineered Paliperidone Nanoemulsions for Improved Brain Delivery via Nasal Route.

  2025cites this paper
• Nanoemulsion Technology in Oral Drug Delivery: A Path to Enhanced Solubility and Bioavailability.

  2025cites this paper
• NANOTECHNOLOGY-DRIVEN INNOVATIONS IN HYPERTENSION MANAGEMENT: FORMULATION STRATEGIES, CHALLENGES, AND FUTURE DIRECTIONS

  2025cites this paper
• Progress in nasal drug delivery research based on biomaterials

  2025cites this paper
• Design and evaluation of carnosic acid-loaded thermosensitive lipidic nanogels for nasal delivery: ex vivo permeation, nasal ciliotoxicity, and antioxidant assessment

  2025cites this paper
• Improving nasal spray deposition: advances and strategies to overcome anatomical and physiological barriers

  2025cites this paper
• Biostability, In Vivo Antiviral Activity against Respiratory Syncytial Virus, and Pharmacokinetic Profiles of (-)-Borneol Esters.

  2025cites this paper
• Investigation of Rheological Characteristics of Thermosensitive Nasal In Situ Gels Based on P407 and Their Effect on Spray Pattern

  2025cites this paper
• Impact of using amorphous solid dispersions on brain and systemic delivery of intranasally administered phenytoin

  2025cites this paper
• mPEG-PLA micelles for nose-to-brain delivery of crizotinib-heptamethine cyanine dye conjugate for potential treatment of glioblastoma

  2025cites this paper
• Nasal Spray Disinfectant for Respiratory Infections Based on Functionalized Silver Nanoparticles: A Physicochemical and Docking Approach

  2025cites this paper
• Intranasal sertraline for the investigation of nose-to-brain delivery to mitigate systemic exposure

  2025cites this paper
• Polysaccharides: New Frontiers for Nasal Administration of Medicines

  2025cites this paper
• Developing intranasally administered electro-responsive nanodrugs for rapid epilepsy treatment

  2025cites this paper
• Fentanyl or esketamine for traumatic pain (FORE-PAIN) trial: study protocol for a double-blind multi-arm randomized non-inferiority trial

  2025cites this paper
• The pharmacokinetics, bio-distribution and therapeutic efficacy of a trimeric nanobody against SARS-CoV-2 in the Syrian golden hamster COVID-19 model

  2025cites this paper
• Optimizing pediatric premedication for general anesthesia: A comprehensive Bayesian network meta-analysis.

  2025cites this paper
• Intranasal Dimethyl Trisulfide: Long-Term Efficacy in an Acutely Lethal Large Swine Model of Cyanide Exposure

  2025cites this paper
• IFN-γ and IL-17 elicit synergistic anti-mycobacterial responses by inhibiting coronin-1A retention

  2025cites this paper
• The review of nasal drug delivery system: The strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption.

  2025cites this paper
• Heparin-Azithromycin Microparticulate Nasal Gels Block SARS-CoV-2 and Bacterial Respiratory Infections

  2025cites this paper
• Nasal Versus Sublingual Routes for Emergency Drug Administration.

  2025cites this paper
• A comparative study of detomidine delivery via intranasal or intramuscular routes in calves undergoing disbudding.

  2024cites this paper
• Clinical evaluation of the sedative, antinociceptive and cardiorespiratory effects of intranasal dexmedetomidine combined with methadone in healthy dogs.

  2024cites this paper
• Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations

  2024cites this paper
• Nose-to-Heart Approach: Unveiling an Alternative Route of Acute Treatment

  2024cites this paper
• Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment

  2024cites this paper
• Serum Albumin in Nasal Drug Delivery Systems: Exploring the Role and Application

  2024influential citation
• Nose to brain delivery of flurbiprofen from a solid lipid nanoparticles-based thermosensitive in-situ gel.

  2024cites this paper
• Intranasal delivery of herbal medicine for disease treatment: A systematic review.

  2024cites this paper
• Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery

  2024cites this paper
• Anatomically-detailed segmented representative adult and pediatric nasal models for assessing regional drug delivery and bioequivalence with suspension nasal sprays.

  2024cites this paper
• Intranasal therapies for neonatal hypoxic-ischemic encephalopathy: Systematic review, synthesis, and implications for global accessibility to care

  2024cites this paper
• Trends on Novel Targets and Nanotechnology-Based Drug Delivery System in the Treatment of Parkinson's disease: Recent Advancement in Drug Development.

  2024cites this paper
• Advances in Polysaccharide-Based Formulations for Intranasal Drug Delivery: A Review

  2024cites this paper
• Unlocking Dendrimers Future Potential for Brain-Specific Drug Delivery in Cerebroanoreach.

  2024cites this paper
• Bystander-application of a novel nasal swab optimized for drug delivery is safe and non-traumatic for the general population.

  2024cites this paper
• Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement.

  2024cites this paper
• The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats

  2024cites this paper
• The effect of intranasal Medetomidine/Ketamine and Diazepam/Ketamine combinations on tear production and intraocular pressure in dogs

  2024cites this paper
• Intranasal Fentanyl Versus Morphine in Fracture Reduction in a Pediatric Trauma Center

  2024cites this paper
• Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems

  2024cites this paper
• Mathematical Modeling of the Drug Particles Deposition in the Human Respiratory System - Part 1: Development of Virtual Models of the Upper and Lower Respiratory Tract

  2024cites this paper
• Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules

  2024cites this paper
• Comparison of the effects of intranasal and intramuscular midazolam-butorphanol-ketamine on intraocular pressure, tear production and sedation in New Zealand White rabbits.

  2024cites this paper
• In-Vitro, Ex-Vivo & In-Vivo Assessment of Brain Targeted Thermoreversible Mucoadhesive In-Situ Intranasal Gel of Carmustine for the Treatment of Glioblastoma

  2024cites this paper
• Nanocarriers-mediated nose-to-brain drug delivery: A novel approach for the management of Alzheimer’s Disease

  2024cites this paper
• A comprehensive review on lipid-based nanoparticles via nose to brain targeting as a novel approach

  2024cites this paper
• Absorption pharmacokinetics and feasibility of intranasal dexmedetomidine in patients under general anaesthesia

  2024cites this paper
• Parenteral, Non-Intravenous Analgesia in Acute Traumatic Pain—A Narrative Review Based on a Systematic Literature Search

  2024cites this paper
• Nanoparticle-based Gene Therapy for Neurodegenerative Disorders.

  2024cites this paper
• In Vitro Evaluation of Intersubject Variability in Pediatric Intranasal Drug Delivery Using Nasal Spray Suspension Products

  2024cites this paper
• Formulation of nasal analgesic sprays with diclofenac sodium, ibuprofen, paracetamol, and evaluation of in vitro toxicity

  2024cites this paper
• A Comparative Study of Parent and Child Perspectives on Using the Intranasal Mucosal Atomization Device for Behavior Management in Pediatric Dental Sedation

  2024cites this paper
• Development of Nanomedicines for the Treatment of Alzheimer's Disease: Raison d'être, Strategies, Challenges and Regulatory Aspects.

  2024cites this paper
• Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

  2024cites this paper
• Characterization of anatomical variations of the nasal cavity in a subset of European patients and their impact on intranasal drug delivery.

  2024cites this paper
• A Breath of Fresh Air: Perspectives on Inhaled Nutrients and Bacteria to Improve Human Health

  2024cites this paper
• Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges

  2024influential citation
• The Role of Amphiphilic Compounds in Nasal Nanoparticles

  2024cites this paper
• A randomized double-blinded study assessing the effect of different doses of transnasal dexmedetomidine on the median effective concentration of ropivacaine for a caudal block

  2024cites this paper
• Evaluation of Intranasal Fentanyl and Midazolam Among Inpatient Pediatric Patients.

  2024cites this paper
• Effect of Particle Size versus Surface Charge on the Brain Targeting Behaviour of Elastic Nanovesicles: In-Vitro Characterization, Comparison between I-optimal and D-optimal Statistical Optimization and In-vivo Pharmacokinetic Evaluation

  2024cites this paper
• Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract

  2024cites this paper
• ENHANCING NOSE- TO- BRAIN DELIVERY OF PIRIBEDIL: DEVELOPMENT OF A NANOSUSPENSION DISPERSED IN NASAL IN-SITU GELLING SYSTEM

  2024cites this paper
• Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases

  2023cites this paper
• Effectiveness of Intranasal Analgesia in the Emergency Department

  2023cites this paper
• Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases

  2023cites this paper
• Intranasal administration nanosystems for brain-targeted drug delivery

  2023cites this paper